Pharmaceutical company King Pharmaceuticals Inc (NYSE:KG) reported on 1 June that the company has elected John J. Howarth as vice president of investor relations.
Most recently Howarth served as vice president of investor relations at Alpharma Inc, a company that was acquired by King in December 2008. Previously he was engaged in similar roles at MedPointe Pharmaceuticals and Kos Pharmaceuticals.
No comments:
Post a Comment